- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Events 227 results
Webinar
февраля 15, 2022
Environmental Justice in Regulatory Permitting, Transactions, and Litigation
Webinar
февраля 9, 2022
Key Food and Beverage Issues: What to Expect in 2022
Webinar
февраля 2, 2022
Looking Ahead in Special Situations
Webinar
февраля 1, 2022
Annual Healthcare Fraud Enforcement Update: What does 2022 Hold?
Webinar
января 26, 2022
California MCLE Institute
Webinar
января 25, 2022
2021 Year in Review for Drug and Device Advertising and Promotion – Lessons Learned From FDA Enforcement Letters and Other Key Developments
Webinar
декабря 16, 2021
White Bagging 2.0: Strategies Based on How Providers, Plans and Regulators Have Responded
Webinar
декабря 8, 2021
Talk im Turm – Impact of the new German sales law on the food and life sciences industries
Webinar
декабря 1, 2021
Ransomware for Healthcare Providers: What You Need To Know Right Now
Webinar
ноября 30, 2021
Pharmaceutical and Medical Device Enforcement Developments & Trends in 2021
Webinar
ноября 16, 2021
The Biden Administration’s New OSHA and CMS Rules: Implications for Healthcare Providers
Webinar
ноября 9, 2021
King & Spalding Pharmaceutical University 2021